Upcoming TCVMA CE Meeting
| January | ||
| Event: | CE Meeting | |
| Topic: | “Verdinexor: A Novel Oral Therapy for Canine Lymphoma” & “Zennovation in Sedation: Rethining What is Possible” | |
| Speaker: | Michael D. LaRosh, D.V.M. | |
| Bio: |  Dr. LaRosh graduated with a D.V.M. from Kansas State University in 1983. He worked in a mixed animal practice in central Kansas for 12 years. In 1995, Dr. LaRosh joined Fort Dodge Animal Health and was responsible for evaluating and trending adverse event data and communicating with regulatory groups such as FDA, EPA, and USDA. In October of 2009 Dr. LaRosh joined Bayer Animal Health as a Senior Technical Services Veterinarian and focused on preventive parasitology in pets and enhancing communications skills within the veterinary healthcare team. Dr. LaRosh joined Dechra in February 2015 as the director of Pharmacovigilance and Veterinary Technical Services and managed mandatory regulatory reporting and the filed based Technical Services team. In October 2017, he returned to a field based Technical Services position to help veterinarians and staff manage challenging endocrine and dermatology cases and enhance client communication. | |
| Sponsor: |  | |
| Location: | University of North Texas Health Science Center, Room 114 Beyer Hall 3500 Camp Bowie Blvd. Fort Worth, TX 76107 | |
| Date: | January 19, 2023 | |
| CE Credit: | 2.5 hours | |
Upcoming Events
View Our Calendar
President’s Message
Happy New Year
2022 had some great speakers and we are looking forward to having more this year. A huge thank you to Dr. Blake Rochel who did an amazing job leading us in 2022. I am excited to continue his legacy, and the legacy of other past presidents as we enter the new year.
I would like to introduce myself. I am a 1998 graduate from Texas A&M University and have been practicing in the DFW area for the past 25 years. I started at a practice in Highland Park, transitioned to an associate position at a corporate practice, and now I am in a mixed animal practice east of Fort Worth. Although I practice primarily in a GP setting, I have the opportunity to work at a local emergency clinic one day/week to learn and continue to grow as a practitioner. The saying we truly never stop learning is especially true in veterinary medicine.
Our first speaker of the year comes to us from Dechra, with a new oral treatment for lymphoma. We lose so many patients every year to this devastating cancer. Dechra recently acquired the rights to this medication from Anavive and are striving to make it more affordable and more readily available to us as general practitioners. Dr. LaRosh will be speaking about Laverdia as a new lymphoma chemotherapy medication. He will also be speaking about the new injectable sedation medication Zenalpha. I look forward to seeing all of you at the meeting on January 19, 2023 at the UNT Health Sciences Center.
Regards
Sarah Priebe, DVM